PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ApoE4 1,525 Target Disease Hypertriglyceridemia 7,877 25 0.01 -0.99 0.02 0.66
ApoE4 1,525 Target Disease Insomnia 12,434 1 0.00 -1.00 0.00 0.54
ApoE4 1,525 Target Disease Prostate Cancer 71,064 1 0.00 -1.00 0.00 0.50
ApoE4 1,525 Target Disease Non Insulin Dependent Diabetes Mellitus 6,686 2 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Target Cytokeratin 18 1,108 2 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Disease Urticaria 10,717 2 0.00 -1.00 0.00 0.54
Erbb2 4,536 Target Disease Mesothelioma 11,198 5 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Disease Glioblastoma 17,933 37 0.00 -0.99 0.01 0.62
ApoE4 1,525 Target Disease Bladder Cancer 21,509 1 0.00 -1.00 0.00 0.53
ApoE4 1,525 Target Disease Hepatitis B 57,815 1 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Infertility 35,448 2 0.00 -1.00 0.00 0.51
ApoE4 1,525 Target Disease Shock 134,031 2 0.00 -1.00 0.00 0.50
ApoE4 1,525 Target Target APOA1 958 10 0.01 -0.99 0.01 0.70
ApoE4 1,525 Target Disease Anemia 81,663 2 0.00 -1.00 0.00 0.51
ApoE4 1,525 Target Disease Diabetic Nephropathy 12,496 1 0.00 -1.00 0.00 0.54
ApoE4 1,525 Target Disease Arthritis 128,324 4 0.00 -1.00 0.00 0.52
ApoE4 1,525 Target Disease Sleep Apnea 18,342 3 0.00 -1.00 0.00 0.56
ApoE4 1,525 Target Target Methylenetetrahydrofolate Reductase 3,573 6 0.00 -1.00 0.00 0.63
ApoE4 1,525 Target Disease Pneumonia 81,521 3 0.00 -1.00 0.00 0.52
ApoE4 1,525 Target Disease Cerebral Edema 3,889 3 0.00 -1.00 0.00 0.61
ApoE4 1,525 Target Disease Coma 24,208 3 0.00 -1.00 0.00 0.55
ApoE4 1,525 Target Disease Stroke 146,992 41 0.00 -0.99 0.03 0.58
ApoE4 1,525 Target Disease Sedation 27,984 1 0.00 -1.00 0.00 0.52
ApoE4 1,525 Target Disease Ventricular Dysfunction 12,856 1 0.00 -1.00 0.00 0.54
ApoE4 1,525 Target Target Adiponectin 11,994 2 0.00 -1.00 0.00 0.56
ApoE4 1,525 Target Target ERK1 18,374 2 0.00 -1.00 0.00 0.55
ApoE4 1,525 Target Disease Gallstones 8,280 5 0.00 -1.00 0.00 0.60
ApoE4 1,525 Target Disease Glomerulonephritis 23,459 2 0.00 -1.00 0.00 0.54
ApoE4 1,525 Target Disease Osteoporosis 46,215 6 0.00 -1.00 0.00 0.55
ApoE4 1,525 Target Disease Viral Disease 2,087 1 0.00 -1.00 0.00 0.59
Erbb2 4,536 Target Target aFGF 899 1 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Disease Erythema 22,182 1 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Myelodysplastic Syndrome 7,378 1 0.00 -1.00 0.00 0.53
Erbb2 4,536 Target Target Dna Gyrase 2,022 2 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Disease Brain Tumors 16,749 8 0.00 -1.00 0.00 0.57
Erbb2 4,536 Target Disease Asthma 109,610 3 0.00 -1.00 0.00 0.49
Erbb2 4,536 Target Target bFGF 9,327 6 0.00 -1.00 0.00 0.58
Erbb2 4,536 Target Disease Breast Cancer 173,695 1,718 0.06 -0.78 0.38 0.68
Erbb2 4,536 Target Target Endoglin 1,333 2 0.00 -1.00 0.00 0.59
Erbb2 4,536 Target Disease Leukemia 162,805 75 0.00 -0.99 0.02 0.57
Erbb2 4,536 Target Target Udp-Glucuronosyltransferase 2,219 1 0.00 -1.00 0.00 0.56
Erbb2 4,536 Target Disease Pain 409,851 16 0.00 -1.00 0.00 0.50
Erbb2 4,536 Target Disease Gastritis 17,713 5 0.00 -1.00 0.00 0.55
Erbb2 4,536 Target Target Hypoxia-Inducible Factor 1-Alpha 923 3 0.00 -1.00 0.00 0.61
Erbb2 4,536 Target Target Prostaglandin E2 Receptor Ep4 Subtype 5 2 0.01 -0.77 0.40 0.69
Erbb2 4,536 Target Disease Psoriasis 26,882 2 0.00 -1.00 0.00 0.51
Erbb2 4,536 Target Target CXCL11 526 1 0.00 -1.00 0.00 0.59
Erbb2 4,536 Target Disease Itching 5,798 1 0.00 -1.00 0.00 0.54
Erbb2 4,536 Target Target BMPR1A 279 1 0.00 -1.00 0.00 0.60
Erbb2 4,536 Target Target Retinoic Acid Receptor Alpha 1,068 6 0.00 -1.00 0.01 0.63